China Expansion Press Release

Hematogenix Announces the Opening of Their Newest Facility in Shanghai, China

 PD-L1 Press Release

Hematogenix Laboratory Services, LLC Introduces the Availability of PD-L1 Companion Diagnostic Tests

THxID®-BRAF Press Release

Hematogenix Laboratory Services to Offer FDA Approved THxID®‐BRAF Companion Diagnostic Testing Services in the US

RNAscope®-ISH Press Release 

Hematogenix Laboratory Services – The First Diagnostic Testing and CLIA-Certified Biomarker Services Laboratory to Offer Advanced Cell Diagnostics, RNAscope® Assays to Clients

New Test Offering - MRD-CLL

Hematogenix Laboratory Services Launches Minimal Residual Disease (MRD) Evaluation for Chronic Lymphocytic Leukemia (CLL) Using the Standardized ERIC Method

Hematogenix Launches FDA Approved Companion Diagnostic Immuno-oncology Test for Triple-Negative Breast Cancer

Hematogenix Launches FDA Approved Companion Diagnostic Immuno-oncology Test for Triple-Negative Breast Cancer